{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:32Z","timestamp":1760188412383},"reference-count":221,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1990,6,1]],"date-time":"1990-06-01T00:00:00Z","timestamp":644198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[1990,6]]},"DOI":"10.1016\/0011-5029(90)90013-h","type":"journal-article","created":{"date-parts":[[2004,6,30]],"date-time":"2004-06-30T12:27:29Z","timestamp":1088598449000},"page":"323-371","source":"Crossref","is-referenced-by-count":7,"title":["Myeloma"],"prefix":"10.1016","volume":"36","author":[{"given":"Peter","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0011-5029(90)90013-H_BIB1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0609.1985.tb00791.x","article-title":"Some reflections on myeloma","volume":"35","author":"Waldenstrom","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0140-6736(67)90935-X","article-title":"Some aspects of the first recorded case of multiple myeloma","volume":"2","author":"Clamp","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0147-0272(78)80006-3","article-title":"Plasma cell neoplasms","volume":"3","author":"Alexanian","year":"1978","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/pgmj.64.756.747","article-title":"Problems of myeloma in a community","volume":"64","author":"Flanagan","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB5","series-title":"An indication of the genetic constitution of population samples in Cape Town","first-page":"1","article-title":"Blood group gene frequencies","volume":"46","author":"Botha","year":"1972"},{"key":"10.1016\/0011-5029(90)90013-H_BIB6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/00325481.1977.11712186","article-title":"Multiple myeloma: Uncommon or uncommonly diagnosed?","volume":"61","author":"Newton","year":"1977","journal-title":"Postgrad Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1200\/JCO.1987.5.12.1977","article-title":"Effects of socioeconomic and clinical factors on survival in multiple myeloma","volume":"5","author":"Weston","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB8","first-page":"153","article-title":"Experimental plasma and cell tumors and other immunoglobulin-producing lymphoreticular neoplasms in mice","volume":"vol 1","author":"Potter","year":"1973"},{"key":"10.1016\/0011-5029(90)90013-H_BIB9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0272-2712(18)30706-6","article-title":"Neoplasms of terminally differentiated B lymphocytes","volume":"8","author":"Holbert","year":"1988","journal-title":"Clin Lab Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005792-198711000-00002","article-title":"Immunoproliferative small-intestinal disease: Clinical features and outcome in 30 cases","volume":"66","author":"Gilinsky","year":"1987","journal-title":"Medicine"},{"key":"10.1016\/0011-5029(90)90013-H_BIB11","series-title":"Progress in Myeloma","first-page":"263","article-title":"Genetic considerations in plasmacytomas of BALB\/c, NZB and (BALB\/c \u00d7 NZB)F1 mice","author":"Morse","year":"1980"},{"key":"10.1016\/0011-5029(90)90013-H_BIB12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/019262338201000109","article-title":"Murine plasma cell neoplasms: Comments on misuse of terms myeloma and hybridoma","volume":"10","author":"Dunn","year":"1982","journal-title":"Toxicol Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB13","series-title":"Multiple myeloma","first-page":"593","article-title":"Animal model of human disease","volume":"132","author":"Radl","year":"1988"},{"key":"10.1016\/0011-5029(90)90013-H_BIB14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1987.241","article-title":"The 5T2 mouse multiple myeloma model: Characterization of 5T2 cells within the bone marrow","volume":"56","author":"Croese","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V73.4.1020.1020","article-title":"The human myeloma cell line LP-1: A versatile model in which to study early plasma-cell differentiation and c-myc activation","volume":"73","author":"Pegoraro","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0008-8749(88)90323-1","article-title":"T- and B-cell-derived supernatant factors enhance IgE synthesis by a myeloma cell line (U-266)","volume":"114","author":"Ray","year":"1988","journal-title":"Cell Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ajcp\/83.5.577","article-title":"Nucleolus-associated localization of J chains in IgG 1 (\u03bb)-producing myeloma cells","volume":"83","author":"Kanoh","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/MCB.5.4.856","article-title":"Independent immunoglobulin class-switch events occurring in a single myeloma cell line","volume":"5","author":"Eckhardt","year":"1985","journal-title":"Mol Cell Biol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0609.1985.tb01568.x","article-title":"The in vitro effect of leucocyte \u03b1-interferon on human myeloma cells in a semisolid culture system","volume":"32","author":"Brenning","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hon.2900060206","article-title":"A culture method for colonies of multiple myeloma cells","volume":"6","author":"Millar","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0145-2126(88)90036-7","article-title":"Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells","volume":"12","author":"Campling","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/0011-5029(90)90013-H_BIB22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood.V73.3.747.747","article-title":"Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation","volume":"73","author":"Dalton","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/hyb.1987.6.679","article-title":"Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells","volume":"6","author":"Jahn","year":"1987","journal-title":"Hybridoma"},{"key":"10.1016\/0011-5029(90)90013-H_BIB24","first-page":"387","article-title":"Increasing trends of multiple myeloma mortality in England and Wales: 1950\u20131979: Are the changes real?","volume":"69","author":"Velez","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0011-5029(90)90013-H_BIB25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910320104","article-title":"International variations and temporal trends in mortality from multiple myeloma","volume":"32","author":"Cuzick","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB26","first-page":"17","article-title":"Incidence and secular trend of multiple myeloma in Olmsted County, Minnesota: 1965\u20131977","volume":"66","author":"Linos","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0011-5029(90)90013-H_BIB27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198402163100703","article-title":"Comparison of trends in the incidence of multiple myeloma in Malmo, Sweden, and other countries, 1950\u20131979","volume":"310","author":"Turesson","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/bjc.1988.118","article-title":"Multiple myeloma: A case-control study","volume":"57","author":"Cuzick","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB29","first-page":"1","article-title":"The survival time of patients with plasmocytic myeloma","volume":"9","author":"Osgood","year":"1960","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/0011-5029(90)90013-H_BIB30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000206109","article-title":"Analysis of human myeloma cell population kinetics","volume":"75","author":"Montecucco","year":"1986","journal-title":"Acta Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V73.4.865.865","article-title":"Plasma cell myeloma: New biological insights and advances in therapy","volume":"73","author":"Barlogie","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hon.2900060203","article-title":"The biology of multiple myeloma","volume":"6","author":"Durie","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-4608(85)90096-2","article-title":"Cytogenetic evidence that the malignant event in multiple myeloma occurs in a precursor lymphocyte","volume":"17","author":"MacKenzie","year":"1985","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.1989.tb07646.x","article-title":"Circulating monoclonal B lymphocytes in multiple myeloma","volume":"72","author":"Chiu","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2141.1989.tb04292.x","article-title":"No detectable malignant B cells in the peripheral blood of patients with multiple myeloma","volume":"71","author":"Clofent","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.1989.tb00114.x","article-title":"Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy","volume":"42","author":"Cohen","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V66.1.229.229","article-title":"CALLA-positive myeloma: An aggressive subtype with poor survival","volume":"66","author":"Durie","year":"1985","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB38","first-page":"6234","article-title":"Ultrastructure of myeloma cells in patients with common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma","volume":"48","author":"Kurabayashi","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/0011-5029(90)90013-H_BIB39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V71.4.861.861","article-title":"Phenotypic heterogeneity in ancuploid multiple myeloma indicates pre-B cell involvement","volume":"71","author":"Epstein","year":"1988","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.V70.4.932.932","article-title":"Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features","volume":"70","author":"Grogan","year":"1987","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0161-5890(85)90096-3","article-title":"Complexes of \u03b11\ue5f8microglobulin and monomeric IgA in multiple myeloma and normal human sera","volume":"22","author":"Vincent","year":"1985","journal-title":"Mol Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood.V66.3.548.548","article-title":"Establishment of two new myeloma cell lines from bilateral pleural effusions: Evidence for sequential in vivo clonal change","volume":"66","author":"Durie","year":"1985","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB43","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJM198406283102607","article-title":"The hypercalcemia of cancer: Clinical implications and pathogenic mechanisms","volume":"310","author":"Mundy","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB44","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM197411142912001","article-title":"Evidence for the secretion of an osteoclast stimulating factor in myeloma","volume":"291","author":"Mundy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1982.tb03936.x","article-title":"Quantitative histology of myeloma-induced bone changes","volume":"52","author":"Valentin-Opran","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM197404182901601","article-title":"Bone-rebsorbing activity in supernatants from lymphoid cell lines","volume":"290","author":"Mundy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM198708273170902","article-title":"Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells","volume":"317","author":"Garrett","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2141.1981.tb02758.x","article-title":"Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma","volume":"47","author":"Durie","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB49","first-page":"1213","article-title":"Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226","volume":"48","author":"Rossi","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/0011-5029(90)90013-H_BIB50","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.136.7.2478","article-title":"Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro","volume":"136","author":"Gowen","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hon.2900020402","article-title":"Non-random chromosomal aberrations associated with multiple myeloma","volume":"2","author":"Lewis","year":"1984","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V59.1.43.43","article-title":"Ploidy and proliferative characteristics in monoclonal gammopathies","volume":"59","author":"Latrille","year":"1982","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB53","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(197908)44:2<630::AID-CNCR2820440233>3.0.CO;2-G","article-title":"Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders","volume":"44","author":"Liang","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB54","series-title":"A banding study of 25 cases","first-page":"243","article-title":"Chromosomes and survival in multiple myeloma","volume":"2","author":"Philip","year":"1980"},{"key":"10.1016\/0011-5029(90)90013-H_BIB55","first-page":"208a","article-title":"Abnormalities of chromosome 6q in osteoclast activating factor (OAF; TNF\u03b2) production in multiple myeloma","volume":"68","author":"Durie","year":"1986","journal-title":"Exp Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB56","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V72.4.1163.1163","article-title":"Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele","volume":"72","author":"Ernst","year":"1988","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB57","first-page":"5125","article-title":"Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein","volume":"46","author":"Dalton","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/0011-5029(90)90013-H_BIB58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1988.tb06190.x","article-title":"Reversal of drug-resistance in multiple myeloma with verapamil","volume":"68","author":"Durie","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jnci\/81.2.84","article-title":"Does P-glycoprotein predict response to chemotherapy?","volume":"81","author":"Ling","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0011-5029(90)90013-H_BIB61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajh.2830300202","article-title":"Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance","volume":"30","author":"Pilarski","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1989.tb04258.x","article-title":"Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"71","author":"Shapira","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB63","first-page":"533","article-title":"Production of interleukin 2 in multiple myeloma","volume":"63","author":"Commes","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archinte.1972.03650010041008","article-title":"Bone pain in multiple myeloma","volume":"130","author":"Charkes","year":"1972","journal-title":"Arch Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB65","first-page":"53","article-title":"Brief review: Diagnosing and managing plasma cell (multiple) myeloma","volume":"33","author":"Mass","year":"1978","journal-title":"Geriatrics"},{"key":"10.1016\/0011-5029(90)90013-H_BIB66","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0037-198X(74)90019-4","article-title":"The many facets of multiple myeloma","volume":"9","author":"Meszaros","year":"1974","journal-title":"Semin Roentgenol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB67","first-page":"1246","article-title":"Osteosclerotic myeloma with peripheral neuropathy","volume":"48","author":"Getaz","year":"1974","journal-title":"S Afr Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB68","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/archinte.1985.00360110149029","article-title":"Ten-year survival in multiple myeloma","volume":"145","author":"Alexanian","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ajh.2830300315","article-title":"Seventeen-year survival in multiple myeloma","volume":"30","author":"Suyehira","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM195911052611906","article-title":"Plasma cell myeloma. II: Clinical aspects","volume":"261","author":"Osserman","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1148\/58.2.178","article-title":"Variation in the roentgen appearance of the skeletal system in myeloma","volume":"58","author":"Heiser","year":"1951","journal-title":"Radiology"},{"key":"10.1016\/0011-5029(90)90013-H_BIB72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.42.3.246","article-title":"Bulky extramedullary plasmacytomata: Rare mode of relapse in myelomatosis","volume":"42","author":"Davies","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB73","series-title":"A study of five cases and a review of the literature","first-page":"892","article-title":"Plasma cell neoplasia with osteosclerotic lesions","volume":"139","author":"Driedger","year":"1979"},{"key":"10.1016\/0011-5029(90)90013-H_BIB74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(87)92383-X","article-title":"Magnetic resonance imaging of the spine in multiple myeloma","volume":"2","author":"Ludwig","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB75","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0140-6736(88)91973-3","article-title":"Magnetic resonance imaging in myeloma","volume":"1","author":"Joffe","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB76","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(84)92744-2","article-title":"Polymyositis associated with monoclonal gammopathyo","volume":"2","author":"Kiprov","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000206367","article-title":"Multiple myeloma occurring in association with a preexisting neuromuscular disease (progressive muscular dystrophy)","volume":"72","author":"Kissling","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB78","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/00007611-198412000-00026","article-title":"Connective tissue disease manifested as multiple myeloma","volume":"77","author":"Tula","year":"1984","journal-title":"South Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB79","first-page":"1202","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB80","first-page":"65","article-title":"Dialysis in the treatment of multiple myeloma","volume":"55","author":"Johnson","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/0011-5029(90)90013-H_BIB81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00005792-197803000-00003","article-title":"Renal function in patients with multiple myeloma","volume":"57","author":"DeFronzo","year":"1978","journal-title":"Medicine"},{"key":"10.1016\/0011-5029(90)90013-H_BIB82","first-page":"206","article-title":"Severe renal failure in multiple myeloma","volume":"15","author":"Cosio","year":"1981","journal-title":"Clin Nephrol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB83","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/archinte.1982.00340250041008","article-title":"Reversible renal insufficiency in multiple myeloma","volume":"142","author":"Bernstein","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB84","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/bmj.287.6405.1575","article-title":"Should patients with renal failure associated with myeloma be dialysed?","volume":"287","author":"Coward","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(84)90781-2","article-title":"Acute renal failure in patients with multiple myeloma","volume":"76","author":"Cohen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.292.6512.2","article-title":"The kidney in myeloma","volume":"292","author":"Hamblin","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005792-198703000-00004","article-title":"Multiple myeloma and severe renal failure: A clinicopathologic study of outcome and prognosis in 34 patients","volume":"66","author":"Rota","year":"1987","journal-title":"Medicine"},{"key":"10.1016\/0011-5029(90)90013-H_BIB88","first-page":"640","volume":"1","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB89","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9681(71)90076-2","article-title":"Renal complications in multiple myeloma: Pathophysiology and some aspects of clinical management","volume":"24","author":"Martinez-Maldonada","year":"1971","journal-title":"J Chronic Dis"},{"key":"10.1016\/0011-5029(90)90013-H_BIB90","series-title":"A study of 66 patients","first-page":"2408","article-title":"The clinical spectrum of pure Bence Jones proteinuria","volume":"62","author":"Pascali","year":"1988"},{"key":"10.1016\/0011-5029(90)90013-H_BIB91","first-page":"93","article-title":"Association of systemic light-chain deposition disease and amyloidosis: A report of three patients with renal involvement","volume":"24","author":"Jacquot","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB92","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0046-8177(88)80280-6","article-title":"Pathology of dysproteinemia: Light chain amyloidosis, nonamyloid immunoglobulin deposition disease, cryoglobulinemia syndromes, and macroglobulinemia of Waldenstrom","volume":"19","author":"Feiner","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB93","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/pgmj.47.552.635","article-title":"Factors influencing the prognosis in myelomatosis","volume":"47","author":"Dawson","year":"1971","journal-title":"Postgrad Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB94","first-page":"139","article-title":"Adult Fanconi syndrome in kappa light chain myeloma","volume":"111","author":"Chan","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB95","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1365-2559.1986.tb02543.x","article-title":"Systemic kappa light chain deposition and amyloidosis in multiple myeloma: Novel morphological observations","volume":"10","author":"Kirkpatrick","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/0011-5029(90)90013-H_BIB96","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/bjc.1982.141","article-title":"Anaemia in patients with myelomatosis","volume":"45","author":"Ting","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(61)91420-9","article-title":"Myelomatosis","volume":"1","author":"Innes","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB98","first-page":"29","article-title":"Multiple myeloma: Review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/0011-5029(90)90013-H_BIB99","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/bjc.1980.328","article-title":"Report on the second myelomatosis trial after 5 years of follow-up","volume":"42","author":"Medical Research Council","year":"1980","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jcp.20.5.699","article-title":"Incidence and pathogenesis of megaloblastic erythropoiesis in multiple myeloma","volume":"20","author":"Hoffbrand","year":"1967","journal-title":"J Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0609.1978.tb00362.x","article-title":"Bone marrow studies in myelomatosis","volume":"21","author":"Hansen","year":"1978","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0609.1979.tb00431.x","article-title":"Quantitation of erythropoiesis in myelomatosis","volume":"22","author":"Birgens","year":"1979","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB103","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.0954-6820.1969.tb01506.x","article-title":"Plasma volume, colloid osmotic pressure and gamma globulin in multiple myeloma","volume":"186","author":"Bjorneboe","year":"1969","journal-title":"Acta Med Scand"},{"key":"10.1016\/0011-5029(90)90013-H_BIB104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V49.2.301.301","article-title":"Blood volume in monoclonal gammopathy","volume":"49","author":"Alexanian","year":"1977","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9343(62)90262-0","article-title":"Studies of the anemia of multiple myeloma","volume":"33","author":"Cline","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0609.1978.tb02483.x","article-title":"Interrelationships between blood volumes, venous haematocrit and renal failure in myelomatosis","volume":"20","author":"Hansen","year":"1978","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB107","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","article-title":"Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"2","author":"Winearls","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB108","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-110-2-108","article-title":"Recombinant human erythropoietin treatment in pre-dialysis patients","volume":"110","author":"Lim","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB109","series-title":"Report of a case and review of the literature","first-page":"121","article-title":"Phagocytic myeloma cells","volume":"84","author":"Kanoh","year":"1985"},{"key":"10.1016\/0011-5029(90)90013-H_BIB110","series-title":"Clinicopathologic syndrome","first-page":"297","article-title":"Plasma cell dyscrasia with marrow fibrosis","volume":"79","author":"Vandermolen","year":"1985"},{"key":"10.1016\/0011-5029(90)90013-H_BIB111","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1987.107","article-title":"A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis","volume":"55","author":"Cuzick","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB112","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007611-198807000-00012","article-title":"Multiple myeloma: Infectious complications","volume":"81","author":"Doughney","year":"1988","journal-title":"South Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000225611","article-title":"Changing patterns of infections in patients with multiple myeloma","volume":"39","author":"Shaikh","year":"1982","journal-title":"Oncology"},{"key":"10.1016\/0011-5029(90)90013-H_BIB114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection on multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB115","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archinte.1980.00330200026012","article-title":"Infections in patients with multiple myeloma","volume":"140","author":"Norden","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB116","first-page":"291","article-title":"Bone destruction and hypercalcemia in plasma cell myeloma","volume":"13","author":"Mundy","year":"1986","journal-title":"Semin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB118","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mpo.2950110410","article-title":"Gastrointestinal involvement with myeloma","volume":"11","author":"Benson","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB119","series-title":"Clinicopathologic Conference: Gastric outlet obstruction in a patient with multiple myeloma","first-page":"141","volume":"68","year":"1980"},{"key":"10.1016\/0011-5029(90)90013-H_BIB120","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/00007611-197911000-00049","article-title":"Plasmacytomas of the breast: An unusual manifestation of multiple myeloma","volume":"72","author":"Bassett","year":"1979","journal-title":"South Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB121","first-page":"870","article-title":"Myeloma cells in the urine","volume":"109","author":"Neal","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","article-title":"Solitary plasmacytoma of bone: Mayo Clinic experience","volume":"16","author":"Frassica","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0011-5029(90)90013-H_BIB123","series-title":"Progress in Myeloma","first-page":"81","article-title":"Plasma cell myeloma and Waldenstrom's macroglobulinemia in black and white South Africans","author":"Jacobson","year":"1980"},{"key":"10.1016\/0011-5029(90)90013-H_BIB124","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ajcp\/63.6.811","article-title":"Orbital and conjunctival involvement in multiple myeloma","volume":"63","author":"Benjamin","year":"1975","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.2830060311","article-title":"Myelomatous pleural effusion: Clinical course and immunologic characterization of the pleural fluid cells","volume":"6","author":"Scullin","year":"1979","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB126","first-page":"178","article-title":"Hypoglossal-nerve palsy in multiple myeloma","volume":"50","author":"Kanoh","year":"1987","journal-title":"Acta Haematol Jpn"},{"key":"10.1016\/0011-5029(90)90013-H_BIB127","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1017\/S0022215100097905","article-title":"Facial palsy due to myeloma of the temporal bone","volume":"99","author":"Shone","year":"1985","journal-title":"J Laryngol Otol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB128","unstructured":"Jacobs P, King HS, Le Roux I, et al: Spinal myeloma and emergency surgery. South Afr Med J, in press."},{"key":"10.1016\/0011-5029(90)90013-H_BIB129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0277-5379(89)90008-4","article-title":"Spinal cord compression in myelomatosis: Response to chemotherapy alone","volume":"25","author":"Sinoff","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/pgmj.64.755.696","article-title":"Massive macroglossia, amyloidosis and myeloma","volume":"64","author":"Jacobs","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0025-7125(16)30974-9","article-title":"Myeloma, paraproteinemias, and the skin","volume":"70","author":"Piette","year":"1986","journal-title":"Med Clin North Am"},{"key":"10.1016\/0011-5029(90)90013-H_BIB132","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1017\/S0022215100097899","article-title":"Myelomatosis presenting as an isolated lesion in the mastoid","volume":"99","author":"Marks","year":"1985","journal-title":"J Laryngol Otol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB133","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2008-1051003","article-title":"Recurrent iritis as an initial symptom of a myeloma (IgG) type: A case report","volume":"187","author":"Huismans","year":"1985","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/0011-5029(90)90013-H_BIB134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.2830190309","article-title":"Obstructive jaundice from hepatic amyloidosis in a patient with multiple myeloma","volume":"19","author":"Calomeni","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S0022215100097942","article-title":"Subglottic plasmacytoma of the larynx: An acute presentation","volume":"99","author":"Gormley","year":"1985","journal-title":"J Laryngol Otol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB136","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jcp.41.7.776","article-title":"Laboratory investigation of paraproteinaemia","author":"Riches","year":"1988","journal-title":"Assoc Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB137","first-page":"141","article-title":"Identification of monoclonal gammopathies: A comparison of immunofixation, immunoelectrophoresis and measurements of kappa- and lambda-immunoglobulin levels","volume":"26","author":"Duc","year":"1988","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB138","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(76)90440-X","article-title":"Manifestations of systemic light chain deposition","volume":"60","author":"Randall","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB139","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00320791","article-title":"The non-producer plasma cell myeloma: Report of a case and review of the literature","volume":"52","author":"Franchi","year":"1986","journal-title":"Blut"},{"key":"10.1016\/0011-5029(90)90013-H_BIB140","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI112033","article-title":"Cytoplasmic immunoglobulin content in multiple myeloma","volume":"76","author":"Barlogie","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/0011-5029(90)90013-H_BIB141","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1986.tb04092.x","article-title":"The incidence and possible relevance of Bence-Jones protein in the sera of patients with multiple myeloma","volume":"62","author":"Sinclair","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB142","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-110-7-521","article-title":"High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma","volume":"110","author":"Barlogie","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB143","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0277-5379(82)90025-6","article-title":"Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status","volume":"18","author":"Bataille","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajh.2830200405","article-title":"Beta 2 microglobulin in multiple myeloma","volume":"20","author":"Alexanian","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ajh.2830180410","article-title":"Multiple myeloma with crystalline inclusions in most hemopoietic cells","volume":"18","author":"Gabriel","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.1988.tb07624.x","article-title":"Plasma cell leukaemia of nonproducer type with missing light chain gene rearrangement","volume":"69","author":"Tominaga","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB147","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1097-0142(19880501)61:9<1782::AID-CNCR2820610910>3.0.CO;2-7","article-title":"Immunophenotypic differences between plasmacytoma\/multiple myeloma and immunoblastic lymphoma","volume":"61","author":"Strickler","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB148","first-page":"351","article-title":"An analysis of myeloma plasma cell phenotype using antibodies defined at the Third International Workshop on Human Leukocyte Differentiation Antigens","volume":"72","author":"Jackson","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB149","unstructured":"Bird AR, Jacobs P, Shuttleworth M: Bone marrow examination in clinical practice, in Greenwood G (ed): The Use of Haematological Testing. New York, Grune & Stratton, in press."},{"key":"10.1016\/0011-5029(90)90013-H_BIB150","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/ajcp\/65.6.921","article-title":"Reactive plasmacytic lesions on the bone marrow","volume":"65","author":"Hyun","year":"1976","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB151","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/pgmj.64.756.804","article-title":"Light chain deposition disease presenting with hepatomegaly: An association with amyloid-like fibrils","volume":"64","author":"Pelletier","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB152","first-page":"145","article-title":"Proposed guidelines for protocol studies. II: Plasma cell myeloma","volume":"4","author":"Committee","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/0011-5029(90)90013-H_BIB153","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(73)90116-2","article-title":"Melphalan and prednisone: An effective combination in the treatment of multiple myeloma","volume":"54","author":"Costa","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB154","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1148\/71.2.157","article-title":"Natural history of multiple myeloma before radiological evidence of disease","volume":"71","author":"Osserman","year":"1958","journal-title":"Radiology"},{"key":"10.1016\/0011-5029(90)90013-H_BIB155","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB156","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/hon.2900060213","article-title":"Prognostic factors and staging systems for multiple myeloma: Comparisons between the Medical Research Council studies in the United Kingdom and the Southwest Oncology Group studies in the United States","volume":"6","author":"Kelly","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB157","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.1989.tb04314.x","article-title":"A new prognostic system for multiple myeloma based on easily available parameters","volume":"72","author":"Blade","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB158","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.1980.330","article-title":"Prognostic features in the third MRC myelomatosis trial","volume":"42","author":"Medical Research Council Working Party on Leukaemia in Adults","year":"1980","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB159","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hon.2900060212","article-title":"Prognostic factors in multiple myeloma","volume":"6","author":"Kyle","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bjc.1989.23","article-title":"Prognostic factors and classification in multiple myeloma","volume":"59","author":"San Miguel","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB161","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood.V56.3.521.521","article-title":"Localized and indolent myeloma","volume":"56","author":"Alexanian","year":"1980","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB162","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","article-title":"Smoldering multiple myeloma","volume":"302","author":"Kyle","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900060102","article-title":"The prognostic significance of X-ray changes at presentation and reassessment in patients with multiple myeloma","volume":"6","author":"Smith","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB164","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V72.1.219.219","article-title":"Value of \u03b22-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma","volume":"72","author":"Greipp","year":"1988","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2141.1982.tb02791.x","article-title":"Bone marrow histology in myeloma: Its importance in diagnosis, prognosis, classification and staging","volume":"51","author":"Bartl","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB166","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hon.2900060209","article-title":"Histologic classification and staging of multiple myeloma","volume":"6","author":"Bartl","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB167","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.1988.6.6.1041","article-title":"Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies","volume":"6","author":"Witzig","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB168","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2141.1985.tb02874.x","article-title":"Serum beta2-microglobulin: A real improvement in the management of multiple myeloma?","volume":"61","author":"Van Dobbenburgh","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB169","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1200\/JCO.1985.3.12.1613","article-title":"Colony growth and self-renewal of plasma cell precursors in multiple myeloma","volume":"3","author":"Takahashi","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(87)90067-5","article-title":"Immunoregulation and prognosis in myeloma","volume":"1","author":"Joshua","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB171","series-title":"A new parameter","first-page":"629","article-title":"Monitoring myeloma: Light chain isotype suppression","volume":"15","author":"Wearne","year":"1985"},{"key":"10.1016\/0011-5029(90)90013-H_BIB172","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.V55.3.364.364","article-title":"Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma","volume":"55","author":"Durie","year":"1980","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB173","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.1989.7.1.119","article-title":"Early responder myeloma: Kinetic studies identify a patient subgroup characterized by very poor prognosis","volume":"7","author":"Boccadoro","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB174","first-page":"149","article-title":"The treatment of multiple myeloma","volume":"10","author":"Farhangi","year":"1973","journal-title":"Semin Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0609.1987.tb01445.x","article-title":"The management of myelomatosis","volume":"39","author":"Galton","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB176","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9343(85)90310-9","article-title":"Age and the treatment of multiple myeloma: Southeastern Cancer Study Group experience","volume":"79","author":"Cohen","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB177","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(85)90848-7","article-title":"Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids\/calcitonin in treatment of cancer-associated hypercalcaemia","volume":"2","author":"Ralston","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB178","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2141.1983.tb02002.x","article-title":"Multiple myeloma: Optimal use of salmon calcitonin in the management of myeloma osteoclastic bone disease","volume":"53","author":"Bataille","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB179","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/bmj.292.6535.1549","article-title":"Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin","volume":"292","author":"Ralston","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1988.6.5.762","article-title":"Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the biphosphonate AHPrBP","volume":"6","author":"Thiebaud","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB181","series-title":"Managed by plasma exchange: monitored by serum tests","first-page":"51","article-title":"Hyperviscosity syndrome in paraproteinemia","volume":"22","author":"Beck","year":"1982"},{"key":"10.1016\/0011-5029(90)90013-H_BIB182","first-page":"140","article-title":"Clinical uses of intravenous immunoglobulins","volume":"25","author":"Berkman","year":"1988","journal-title":"Semin Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB183","first-page":"90","article-title":"Immunoregulatory circuits in myeloma: Levels of cellular immunity in myeloma patients","author":"Ullrich","year":"1982","journal-title":"Clin Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB184","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(89)90014-7","article-title":"Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis","volume":"1","author":"MacDougall","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB185","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/bmj.1.6177.1541","article-title":"Spinal-cord compression in myeloma","volume":"1","author":"Benson","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB186","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-75-5-745","article-title":"Giant cells in bone marrows of patients on high dose fluoride treatment","volume":"75","author":"Duffey","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB187","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/pgmj.63.740.425","article-title":"New treatments in myeloma: Is cure possible?","volume":"63","author":"Malpas","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB188","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0145-2126(85)90075-X","article-title":"Treatment of multiple myeloma: A randomized study of three different regimens","volume":"9","author":"Tribalto","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/0011-5029(90)90013-H_BIB189","unstructured":"Jacobs P: Recent advances in the biology and treatment of myeloma, in Roath S (ed): Haematology Reviews and Communications, in press."},{"key":"10.1016\/0011-5029(90)90013-H_BIB190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hon.2900060214","article-title":"Chemotherapy of myeloma: SWOG studies","volume":"6","author":"Durie","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB191","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hon.2900060215","article-title":"Results of the MRC myelomatosis trials for patients entered since 1980","volume":"6","author":"Maclennan","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB192","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced multiple myeloma refractory to alkylating agents","volume":"310","author":"Barlogie","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/0011-5029(90)90013-H_BIB193","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hon.2900060216","article-title":"Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma","volume":"6","author":"Bergsagel","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB194","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0609.1989.tb00110.x","article-title":"Treatment of multiple myeloma with carboquone prednisolone","volume":"42","author":"Akashi","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mpo.2950170116","article-title":"Phase II trial of Amsacrine in patients with multiple myeloma","volume":"17","author":"Greipp","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB196","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/jnci\/80.6.414","article-title":"Dose intensity analysis of melphalan and prednisone in multiple myeloma","volume":"80","author":"Palmer","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0011-5029(90)90013-H_BIB197","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0609.1989.tb00104.x","article-title":"Intermediate dose (25 mg\/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment","volume":"42","author":"Petrucci","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB198","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0140-6736(83)90739-0","article-title":"High-dose intravenous melphalan for plasma-cell leukaemia and myeloma","volume":"2","author":"McElwain","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB199","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hon.2900060218","article-title":"The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies","volume":"6","author":"Selby","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.1987.tb06175.x","article-title":"High dose melphalan and autologous bone marrow transplantation in high risk myeloma","volume":"67","author":"Harousseau","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB201","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0360-3016(88)90139-3","article-title":"Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma","volume":"15","author":"McIntyre","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0011-5029(90)90013-H_BIB202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(85)80003-7","article-title":"Hemibody irradiation in multiple myeloma","volume":"3","author":"Tobias","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00000421-198804000-00003","article-title":"Sequential half-body irradiation as salvage therapy in chemotherapy-resistant multiple myeloma","volume":"1","author":"Jacobs","year":"1988","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB204","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0360-3016(88)90232-5","article-title":"Radiotherapy in the treatment of multiple myeloma","volume":"15","author":"Bosch","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0011-5029(90)90013-H_BIB205","first-page":"473","article-title":"Alpha-2-interferon\/melphalan\/prednisone in previously untreated patients with multiple myeloma: A phase I\u2013II trial","volume":"70","author":"Cooper","year":"1986","journal-title":"Cancer Treatment Rep"},{"key":"10.1016\/0011-5029(90)90013-H_BIB206","series-title":"Clinical results of a multicentric trial","first-page":"61","article-title":"Recombinant alpha 2b interferon as post maintenance therapy for responding multiple myeloma","volume":"2","author":"Tribalto","year":"1987"},{"key":"10.1016\/0011-5029(90)90013-H_BIB207","first-page":"100","article-title":"Recombinant alpha-interferon as salvage therapy in multiple myeloma","volume":"76","author":"Jacobs","year":"1989","journal-title":"S Afr Med J"},{"key":"10.1016\/0011-5029(90)90013-H_BIB208","first-page":"5","article-title":"INTRON-A (interferon alfa-2b): Clinical overview","volume":"12","author":"Spiegel","year":"1985","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/0011-5029(90)90013-H_BIB209","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0140-6736(88)91759-X","article-title":"Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha-interferon","volume":"1","author":"Roy","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/0011-5029(90)90013-H_BIB210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0609.1986.tb00824.x","article-title":"Bone marrow transplantation in multiple myeloma","volume":"36","author":"Tura","year":"1986","journal-title":"Scand J Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB211","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood.V69.4.1262.1262","article-title":"Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation","volume":"69","author":"Gahrton","year":"1987","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2900060219","article-title":"Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the EBMT Registry","volume":"6","author":"Gahrton","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB213","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.2900060217","article-title":"High dose melphalan for refractory myeloma: The MD Anderson experience","volume":"6","author":"Barlogie","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB214","first-page":"649","article-title":"Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: Its use in autografting in acute leukemia","volume":"17","author":"Laporte","year":"1989","journal-title":"Exp Hematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1200\/JCO.1988.6.5.889","article-title":"Management of refractory myeloma: A review","volume":"6","author":"Buzaid","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB216","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hon.2900050308","article-title":"VAD chemotherapy\u2014toxicity and efficacy\u2014in patients with multiple myeloma and other lymphoid malignancies","volume":"5","author":"Anderson","year":"1987","journal-title":"Hematol Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB217","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bjc.1988.243","article-title":"Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients","volume":"58","author":"Forgeson","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/0011-5029(90)90013-H_BIB218","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.1985.3.5.654","article-title":"Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma","volume":"3","author":"Costanzi","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB219","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V70.3.869.869","article-title":"High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma","volume":"70","author":"Barlogie","year":"1987","journal-title":"Blood"},{"key":"10.1016\/0011-5029(90)90013-H_BIB220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000205925","article-title":"Biology and therapy of multiple myeloma","volume":"78","author":"Barlogie","year":"1987","journal-title":"Acta Haematol"},{"key":"10.1016\/0011-5029(90)90013-H_BIB221","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0277-5379(89)90001-1","article-title":"Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma?","volume":"25","author":"Bergsagel","year":"1989","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001150299090013H?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001150299090013H?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T19:49:27Z","timestamp":1705175367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/001150299090013H"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,6]]},"references-count":221,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,6]]}},"alternative-id":["001150299090013H"],"URL":"https:\/\/doi.org\/10.1016\/0011-5029(90)90013-h","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[1990,6]]}}}